Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...
Patent
1983-07-06
1990-01-02
Martinell, James
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Recombinant dna technique included in method of making a...
435 70, 435 71, 4351721, 4351723, 4352401, 4352402, 435243, 4352523, 435255, 435256, 435320, 43525233, 536 27, 935 12, 935 28, 935 29, 935 52, 935 66, 935 67, 935 70, 935 72, 935 73, C12P 2100, C12P 2102, C12P 2104, C12N 1500, C12N 500, C12N 100, C12N 120, C12N 116, C12N 118, C07H 2104
Patent
active
048913154
ABSTRACT:
Methods and compositions are provided for the cloning and expression of Herpes Simplex Virus (HSV type 1 or type 2) glycoprotein (gD) gene in single-cell host organisms. Also described are methods for culturing these novel single-cell organisms to produce HSV-gene products. The HSV gD-related polypeptides produced by the recombinant DNA techniques described herein may be formulated for use as immunogens in vaccines to protect against HSV-1 and HSV-2 infections.
REFERENCES:
patent: 4237224 (1980-12-01), Cohen et al.
patent: 4332892 (1982-06-01), Ptashne et al.
patent: 4338397 (1982-07-01), Gilbert et al.
patent: 4342832 (1982-08-01), Goeddel et al.
patent: 4349629 (1982-09-01), Carey et al.
patent: 4366246 (1982-12-01), Riggs
patent: 4374127 (1983-02-01), Larson et al.
patent: 4419446 (1983-12-01), Howley et al.
patent: 4430437 (1984-02-01), Hamper et al.
patent: 4618578 (1986-10-01), Burke et al.
Henikoff et al.; Nature 289: 33 (1981).
Zhidkova et al., "Molecular cloning of DNA of Herpes Simplex Viruses", Chem. Abstr. 100: 80679z (1984) of (USSR) Deposited Doc. (1982).
Roberts et al., "A general method for maximizing the expression of a cloned gene", Proc. Natl. Acad. Sci. USA 76: 760 (1979).
Hitzeman et al., "Expression of a Human Gene for Interferon in Yeast", Nature 293: 717 (1981).
Itakura et al., 1977, Science 198; 1056.
Villa-Komaroff et al., 1978, Proc. Natl. Acad. Sci. U.S.A. 75: 3727.
Seeberg et al., 1978; Nature 276: 795.
Mercereau-Puijalon et al., 1978, Nature 275: 505.
Fraser et al., 1978, Proc. Natl. Acad. Sci. USA 75: 5936.
Guarente et al., 1980, Cell 20: 543.
Norrild, Current Topics in Microbiol. and Immunol. 19:67.
Ruyechan et al., 1979, J. Virol. 29:667.
Lee et al., 1982, J. Virol. 43:41.
Umene et al., 1981, Gene 13:251.
Watson et al., 1981, J. Virol. 37:431.
Marsden et al., J. Virol. 28:624 (1978).
Halliburton, J. Gen. Virol., 48:1 (1980).
Showalter et al., 1981, Infection and Immunity 34:684.
Eisenberg et al., 1982, J. Virol., 41:478.
Eisenberg et al., 1982, J. Virol, 41: 1099-1104.
Pereira et al., 1982, Infec. Immun. 35:363-367.
Dix et al., 1981, Infec. Immun. 34: 192-199.
Pereira et al., 1980, Infec. Immun. 29:724-732.
Randall et al., 1980, J. Gen. Virol., 48:297-310.
Eisenberg et al., 1980, J. Virol. 35: 428-435.
Cohen et al., 1980, J. Virol. 34:521-531.
Cohen et al., 1978, J. Virol. 27:172-181.
Eisenberg et al., 1979, J. Virol., 31: 608-620.
Cohen et al., 1980, J. Virol., 36: 429-439.
Ponce de Leon et al., 1973, J. Virol., 12: 766-774.
Cohen et al., 1972, J. Virol. 10: 1021-1030.
Pizer et al., 1980, J. Virol., 34: 142-153.
Kreil: Ann. Rev. Biochem. 50: 317 (1981).
Taniguchi et al., Proc. Natl. Acad. Sci. USA 77: 5230 (1980).
Rose et al., Proc. Natl. Acad. Sci. USA 78: 6670 (1980).
Maxam et al., Proc. Natl. Acad. Sci. USA 74: 560 (1977).
Enquist et al., 1979, Science 203: 541-544.
Docherty et al., 1981, J. Virol. 40(1): 126-132.
Galloway et al., 1982, J. Virol. 42(2): 530-537.
Weis et al., 1983, Nature 302: 72-74.
Watson et al., 1982, Science 218: 381-383.
Lee et al., 1982, Proc. Natl. Acad. Sci. U.S.A. 79: 6612-6616.
Berman et al., Trends in Biochemistry, vol. 3, pp. 51-53 (1985).
Post, et al.-Proceedings National Academy of Science, U.S.A., vol. 77, No. 7, pp. 4201-4205, Jul. 1980.
Enquist Lynn W.
Watson Roger J.
Weis John H.
American Cyanamid Company
Martinell James
Raymond Robert P.
LandOfFree
Production of herpes simplex viral porteins does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Production of herpes simplex viral porteins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Production of herpes simplex viral porteins will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1383484